P

Price Vision Group | Indianapolis, IN

Research site
(Unclaimed)
Location
9002 North Meridian Street Suite 100, Indianapolis, Indiana, United States of America
Site insights

Top conditions

Fuchs' Endothelial Dystrophy (13 trials)

Dry Eye Syndromes (6 trials)

Keratoconjunctivitis Sicca (6 trials)

Keratoconus (5 trials)

Corneal Edema (4 trials)

Top treatments

riboflavin
Netarsudil
KPI-121
AGN-190584
LX201
prednisolone acetate
loteprednol etabonate
Anecortave Acetate
Dexamethasone
AGN-199201

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

11 of 50
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) (PHANTOM)

This is a Phase IIa study to assess efficacy and safety of STN1010904 ophthalmic suspension (0.03%, and 0.1 %), twice daily dosing when compared to P...

Enrolling
Fuchs Endothelial Corneal Dystrophy
Drug: STN1010904 ophthalmic suspension 0.03% BID
Drug: Placebo (Vehicle) BID

This study will determine the safety and effectiveness of the Artisan Aphakia Lens when used as a secondary implant to correct aphakia in adults.

Enrolling
Aphakia
Device: Artisan Aphakia Intraocular Lens

The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.

Enrolling
Keratoconus
Ectasia Corneal
Combination Product: riboflavin 0.1%
Combination Product: Riboflavin 0.1%

The study objective is to assess safety and efficacy of photo-activation of riboflavin for treatment of corneal neovascularization with or without co...

Enrolling
Corneal Neovascularization
Combination Product: 10 minute photoactivation of riboflavin 0.1%
Combination Product: 30 minute photoactivation of riboflavin 0.1%

The purpose of the study is to compare the efficacy and safety of 5% tavilermide ophthalmic solution to placebo for the treatment of the signs and sy...

Active, not recruiting
Dry Eye Syndromes
Dry Eye Disease
Other: Vehicle ophthalmic solution
Drug: 5% Tavilermide ophthalmic solution

The purpose of the study is to determine the safety and efficacy of brief intraoperative corneal endothelial graft incubation in plasma rich in growt...

Begins enrollment this month
Corneal Edema
Fuchs' Endothelial Dystrophy
Procedure: PRGF

The purpose of this study is to study the long term safety and effectiveness of an artificial iris prosthesis for the treatment of iris defects.

Enrolling
Partial Aniridia
Full Aniridia
Device: Artificial Iris (CustomFlex)

This study is being conducted to evaluate the safety and effectiveness of using the PXL Platinum 330 System with riboflavin solution for performing c...

Enrolling
Corneal Ulcer
Keratitis
Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution
Other: Standard of Care Therapy + Sham CXL + Artificial Tears

This study is being conducted to evaluate the safety and effectiveness of using the PXL Platinum 330 System with riboflavin solution for performing c...

Enrolling
Corneal Ulcer
Keratitis
Other: Sham CXL + Artificial Tears
Combination Product: PXL Platinum 330 system + Riboflavin 0.25% TE Solution

The objective of this study is to evaluate the long term (i.e. 24 months) clinical performance of the Visian® Toric Implantable Collamer® Lens (ICL).

Active, not recruiting
Myopic Astigmatism
Device: Visian TICL

This study will enroll subjects with stage 2 or 3 neurotrophic keratitis. Subjects will be randomized in a 1:1 ratio to the CSB-001 investigational t...

Enrolling
Neurotrophic Keratitis
Biological: Vehicle Control
Biological: CSB-001 Ophthalmic Solution 0.1%

Trial sponsors

P

Price Vision Group (11 trials)

Glaukos logo

Glaukos (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems